CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 
 

VIR's Net Income Growth by Quarter and Year

Vir Biotechnology Inc 's Net Income results by quarter and year




VIR Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 525.25 -105.65 48.31
III Quarter September 175.31 110.43 -84.61 -48.31
II Quarter June -76.49 61.81 -31.17 0.00
I Quarter March 518.62 -168.91 -77.24 0.00
FY   617.44 528.58 -298.67 0.00



VIR Net Income third quarter 2022 Y/Y Growth Comment
Vir Biotechnology Inc achieved in the third quarter 2022, above Company average Net Income rise of 58.75% year on year, to $ 175.31 millions.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 11 other companies have achieved higher Net Income growth. While Vir Biotechnology Inc ' s Net Income jump of 58.75% ranks overall at the positon no. 547 in the third quarter 2022.




VIR Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September 58.75 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vir Biotechnology Inc 's third quarter 2022 Net Income $ 175.31 millions VIR's Income Statement
Vir Biotechnology Inc 's third quarter 2021 Net Income $ 110.43 millions Quarterly VIR's Income Statement
New: More VIR's historic Net Income Growth >>


VIR Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 375.64 % - -
III Quarter September - 78.66 % - -
II Quarter June - - - -
I Quarter March -1.26 % - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #12
Healthcare Sector #40
Overall #547

Net Income Y/Y Growth Statistics
High Average Low
130.07 % 41.57 % -11.37 %
(Mar 31 2022)   (Jun 30 2022)
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #12
Healthcare Sector #40
Overall #547
Net Income Y/Y Growth Statistics
High Average Low
130.07 % 41.57 % -11.37 %
(Mar 31 2022)   (Jun 30 2022)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Vir Biotechnology Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
375.65 % 151.01 % -1.26 %
(Dec 31 2021)  


VIR's III. Quarter Q/Q Net Income Comment
III. Quarter 2022Periodic Vir Biotechnology Inc in the influence net loss of $ 175.31 millionsPeriodic influence appear to have contributed Vir Biotechnology Inc 's return to profitability, as VIR clinchesNet Income of $ 175.31 millions in the III. Quarter 2022 emanate net loss-76.49 millions in the second quarter. Vir Biotechnology Inc announced in the III. Quarter 2022 Net Income of $ 175.31 millions compare to net loss recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Net Income growth. While Vir Biotechnology Inc 's Net Income growth quarter on quarter, overall rank is 0.


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Statistics
High Average Low
375.65 % 151.01 % -1.26 %
(Dec 31 2021)  


VIR's III. Quarter Q/Q Net Income Comment
III. Quarter 2022Periodic Vir Biotechnology Inc in the circumstances net loss of $ 175.31 millionsPeriodic circumstances have led to Vir Biotechnology Inc 's return to profitability, as VIR clinchesNet Income of $ 175.31 millions in the III. Quarter 2022 emerging from net loss-76.49 millions in the second quarter. Vir Biotechnology Inc announced in the III. Quarter 2022 Net Income of $ 175.31 millions compare to net loss recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Net Income growth. While Vir Biotechnology Inc 's Net Income growth quarter on quarter, overall rank is 0.


Vir Biotechnology Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ 1,142.69 $ 1,077.81 $ 1,216.12 $ 528.58 $ -102.32
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) 6.02 % -11.37 % 130.07 % - -
Seq. Net Income Growth (TTM) Overall Ranking # 547 # 1949 # 116 # 0 # 0




Cumulative Net Income growth Comment
Vir Biotechnology Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 58.75% year on year, to $ 1,143 millions if the fiscal year would have ended in Sep 30 2022.
Vir Biotechnology Inc 's trailing twelve months Net Income growth was higher than company's average 0% and higher than % growth in Jun 30 2022. And, Vir Biotechnology Inc realized the fastest Net Income growth, in Biotechnology & Pharmaceuticals industry.
But from the previous reporting period increase was less at 6.02 % from $1077.81 millions achieved in the period from Jun 30 2022 to Sep 30 2021 Ashley Fernandes added on.
It appears to be drop-off happening, more obvious as we look at average Q/Q TTM historic increase which is better at41.57%. In the Sep 30 2022 period, Vir Biotechnology Inc had cumulative twelve months Net Income of $ 1,143 millions compare to net loss of $ -102 millions a year ago.

Vir Biotechnology Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
130.07 %
41.57 %
-11.37 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 40
S&P 500 # 547
Cumulative Net Income growth Comment
Vir Biotechnology Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 58.75% year on year, to $ 1,143 millions if the fiscal year would have ended in Sep 30 2022.
Vir Biotechnology Inc 's trailing twelve months Net Income growth was higher than company's average 0% and higher than % growth in Jun 30 2022. And, Vir Biotechnology Inc realized the fastest Net Income growth, in Biotechnology & Pharmaceuticals industry.
But sequential rise was slower at 6.02 % from $1077.81 millions recorded in twelve months ending a quarter before.
We witness drop-off happening, more obvious if you pay attention to the average Q/Q TTM historic increase what is stronger at41.57% Ashley Fernandes published.
The growth is even higher from the previous reporting period clinched at 6.02 % rise from $1077.81 millions in the period from Jun 30 2022 to Sep 30 2021. In the Sep 30 2022 period, Vir Biotechnology Inc had cumulative twelve months Net Income of $ 1,143 millions compare to net loss of $ -102 millions a year ago.

Vir Biotechnology Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
130.07 %
41.57 %
-11.37 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 40
S&P 500 # 547




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
VIR's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for VIR's Competitors
Net Income Growth for Vir Biotechnology Inc 's Suppliers
Net Income Growth for VIR's Customers

You may also want to know
VIR's Annual Growth Rates VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roe VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Dividend Payout Ratio
VIR's Roa VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Comparisons



Companies with similar Net Income jump for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Lsi Industries Inc 99.87%$ 99.872 millions
Abiomed Inc 86.35%$ 86.352 millions
Stryker Corp86.30%$ 86.301 millions
Universal Security Instruments Inc86.27%$ 86.267 millions
American Shared Hospital Services83.33%$ 83.333 millions
Carlisle Companies Incorporated79.24%$ 79.240 millions
Vir Biotechnology Inc 58.76%$ 58.757 millions
United Therapeutics Corporation47.08%$ 47.081 millions
Dexcom Inc 42.74%$ 42.736 millions
Medpace Holdings Inc 35.93%$ 35.931 millions
Zimmer Biomet Holdings Inc 33.20%$ 33.196 millions
Iradimed Corporation33.03%$ 33.026 millions
Eli Lilly And Company30.77%$ 30.772 millions
Bio techne Corp30.09%$ 30.085 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NVDA's Profile

Stock Price

NVDA's Financials

Business Description

Fundamentals

Charts & Quotes

NVDA's News

Suppliers

NVDA's Competitors

Customers & Markets

Economic Indicators

NVDA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071